Clinical trials
Completed Gastroesophageal Reflux trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
679 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 9 |
| 2002 | 11 |
| 2003 | 11 |
| 2004 | 22 |
| 2005 | 40 |
| 2006 | 45 |
| 2007 | 33 |
| 2008 | 54 |
| 2009 | 39 |
| 2010 | 46 |
| 2011 | 23 |
| 2012 | 29 |
| 2013 | 35 |
| 2014 | 27 |
| 2015 | 19 |
| 2016 | 30 |
| 2017 | 35 |
| 2018 | 26 |
| 2019 | 15 |
| 2020 | 21 |
| 2021 | 19 |
| 2022 | 30 |
| 2023 | 17 |
| 2024 | 13 |
| 2025 | 12 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 679 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 85 |
| Takeda | 29 |
| Mayo Clinic | 20 |
| Eisai Inc. | 8 |
| Seoul National University Hospital | 8 |
| University of North Carolina, Chapel Hill | 8 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 8 |
| Universitaire Ziekenhuizen KU Leuven | 7 |
| Asian Institute of Gastroenterology, India | 6 |
| Chong Kun Dang Pharmaceutical | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroesophageal Reflux | 679 |
| Heartburn | 66 |
| Barrett Esophagus | 35 |
| Esophagitis | 19 |
| Obesity | 19 |
| Dyspepsia | 18 |
| Esophagitis, Peptic | 15 |
| Hernia, Hiatal | 15 |
| Asthma | 13 |
| Deglutition Disorders | 13 |
Trials
Showing 26 to 50 of 679. Each trial links to its page on Pharma Observatory.
579 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.